nodes	percent_of_prediction	percent_of_DWPC	metapath
Dronedarone—ALB—Vismodegib—skin cancer	0.128	0.199	CbGbCtD
Dronedarone—ALB—Vemurafenib—skin cancer	0.101	0.157	CbGbCtD
Dronedarone—ABCB1—Vismodegib—skin cancer	0.0669	0.104	CbGbCtD
Dronedarone—CYP3A4—Temozolomide—skin cancer	0.0578	0.09	CbGbCtD
Dronedarone—CYP3A4—Imiquimod—skin cancer	0.0578	0.09	CbGbCtD
Dronedarone—CYP2D6—Vemurafenib—skin cancer	0.0498	0.0775	CbGbCtD
Dronedarone—ALB—Fluorouracil—skin cancer	0.0454	0.0707	CbGbCtD
Dronedarone—CYP3A4—Vismodegib—skin cancer	0.0401	0.0624	CbGbCtD
Dronedarone—ABCB1—Dactinomycin—skin cancer	0.0351	0.0547	CbGbCtD
Dronedarone—CYP3A4—Vemurafenib—skin cancer	0.0317	0.0493	CbGbCtD
Dronedarone—CACNA1S—pes—skin cancer	0.0294	0.258	CbGeAlD
Dronedarone—ABCB1—Docetaxel—skin cancer	0.0181	0.0282	CbGbCtD
Dronedarone—CYP3A4—Docetaxel—skin cancer	0.0109	0.0169	CbGbCtD
Dronedarone—Ageusia—Vismodegib—skin cancer	0.0081	0.0387	CcSEcCtD
Dronedarone—CACNA1D—ear—skin cancer	0.00679	0.0597	CbGeAlD
Dronedarone—HCN1—head—skin cancer	0.00597	0.0524	CbGeAlD
Dronedarone—Pulmonary fibrosis—Bleomycin—skin cancer	0.00559	0.0267	CcSEcCtD
Dronedarone—Traumatic liver injury—Temozolomide—skin cancer	0.00556	0.0266	CcSEcCtD
Dronedarone—CACNB4—nipple—skin cancer	0.00539	0.0474	CbGeAlD
Dronedarone—Pulmonary fibrosis—Temozolomide—skin cancer	0.00471	0.0225	CcSEcCtD
Dronedarone—HCN4—head—skin cancer	0.00452	0.0397	CbGeAlD
Dronedarone—Rash erythematous—Imiquimod—skin cancer	0.00452	0.0216	CcSEcCtD
Dronedarone—Hypokalaemia—Vismodegib—skin cancer	0.00434	0.0207	CcSEcCtD
Dronedarone—Vasculitis—Vemurafenib—skin cancer	0.00416	0.0198	CcSEcCtD
Dronedarone—CACNB3—nipple—skin cancer	0.00413	0.0363	CbGeAlD
Dronedarone—Hypomagnesaemia—Bleomycin—skin cancer	0.00387	0.0185	CcSEcCtD
Dronedarone—HCN3—head—skin cancer	0.00366	0.0321	CbGeAlD
Dronedarone—Atrial flutter—Docetaxel—skin cancer	0.00363	0.0173	CcSEcCtD
Dronedarone—Interstitial lung disease—Bleomycin—skin cancer	0.00347	0.0166	CcSEcCtD
Dronedarone—CACNA1F—head—skin cancer	0.00343	0.0301	CbGeAlD
Dronedarone—HCN2—head—skin cancer	0.00343	0.0301	CbGeAlD
Dronedarone—Pulmonary fibrosis—Docetaxel—skin cancer	0.00313	0.015	CcSEcCtD
Dronedarone—Interstitial lung disease—Temozolomide—skin cancer	0.00293	0.014	CcSEcCtD
Dronedarone—Dysgeusia—Vismodegib—skin cancer	0.00281	0.0134	CcSEcCtD
Dronedarone—Eczema—Imiquimod—skin cancer	0.00279	0.0133	CcSEcCtD
Dronedarone—Cardiac failure—Imiquimod—skin cancer	0.00257	0.0123	CcSEcCtD
Dronedarone—Liver injury—Temozolomide—skin cancer	0.00246	0.0118	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Vismodegib—skin cancer	0.00243	0.0116	CcSEcCtD
Dronedarone—CACNB3—mammalian vulva—skin cancer	0.00241	0.0212	CbGeAlD
Dronedarone—Photosensitivity reaction—Vemurafenib—skin cancer	0.00232	0.0111	CcSEcCtD
Dronedarone—Nervous system disorder—Vismodegib—skin cancer	0.0023	0.011	CcSEcCtD
Dronedarone—Skin disorder—Vismodegib—skin cancer	0.00227	0.0109	CcSEcCtD
Dronedarone—CACNB4—head—skin cancer	0.00225	0.0198	CbGeAlD
Dronedarone—CACNB3—female reproductive system—skin cancer	0.00207	0.0182	CbGeAlD
Dronedarone—Dyspepsia—Vismodegib—skin cancer	0.00206	0.00984	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Vismodegib—skin cancer	0.00202	0.00965	CcSEcCtD
Dronedarone—Fatigue—Vismodegib—skin cancer	0.00202	0.00964	CcSEcCtD
Dronedarone—Photosensitivity reaction—Imiquimod—skin cancer	0.00198	0.00945	CcSEcCtD
Dronedarone—Interstitial lung disease—Docetaxel—skin cancer	0.00195	0.0093	CcSEcCtD
Dronedarone—Gastrointestinal pain—Vismodegib—skin cancer	0.00192	0.00914	CcSEcCtD
Dronedarone—Cardiac disorder—Vemurafenib—skin cancer	0.00189	0.00902	CcSEcCtD
Dronedarone—Dermatitis atopic—Docetaxel—skin cancer	0.00186	0.00889	CcSEcCtD
Dronedarone—Abdominal pain—Vismodegib—skin cancer	0.00185	0.00884	CcSEcCtD
Dronedarone—Angiopathy—Vemurafenib—skin cancer	0.00185	0.00882	CcSEcCtD
Dronedarone—Mediastinal disorder—Vemurafenib—skin cancer	0.00184	0.00876	CcSEcCtD
Dronedarone—Hepatobiliary disease—Imiquimod—skin cancer	0.00183	0.00873	CcSEcCtD
Dronedarone—Rash erythematous—Docetaxel—skin cancer	0.0018	0.00859	CcSEcCtD
Dronedarone—CACNB1—head—skin cancer	0.0018	0.0158	CbGeAlD
Dronedarone—Erythema—Vemurafenib—skin cancer	0.00177	0.00846	CcSEcCtD
Dronedarone—Dysgeusia—Vemurafenib—skin cancer	0.00174	0.00829	CcSEcCtD
Dronedarone—CACNB3—head—skin cancer	0.00173	0.0152	CbGeAlD
Dronedarone—Ageusia—Docetaxel—skin cancer	0.0017	0.00812	CcSEcCtD
Dronedarone—Asthenia—Vismodegib—skin cancer	0.00168	0.00802	CcSEcCtD
Dronedarone—Pruritus—Vismodegib—skin cancer	0.00166	0.00791	CcSEcCtD
Dronedarone—ADRA1D—epithelium—skin cancer	0.00162	0.0142	CbGeAlD
Dronedarone—Diarrhoea—Vismodegib—skin cancer	0.0016	0.00765	CcSEcCtD
Dronedarone—CACNA1C—connective tissue—skin cancer	0.00159	0.014	CbGeAlD
Dronedarone—Angiopathy—Imiquimod—skin cancer	0.00158	0.00752	CcSEcCtD
Dronedarone—Immune system disorder—Imiquimod—skin cancer	0.00157	0.00749	CcSEcCtD
Dronedarone—Mediastinal disorder—Imiquimod—skin cancer	0.00157	0.00747	CcSEcCtD
Dronedarone—Erythema—Imiquimod—skin cancer	0.00151	0.00722	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.0015	0.00716	CcSEcCtD
Dronedarone—Vomiting—Vismodegib—skin cancer	0.00149	0.00711	CcSEcCtD
Dronedarone—Rash—Vismodegib—skin cancer	0.00148	0.00705	CcSEcCtD
Dronedarone—Dermatitis—Vismodegib—skin cancer	0.00148	0.00704	CcSEcCtD
Dronedarone—Anaphylactic shock—Vemurafenib—skin cancer	0.00145	0.00691	CcSEcCtD
Dronedarone—Cardiac failure—Fluorouracil—skin cancer	0.00142	0.00678	CcSEcCtD
Dronedarone—Nervous system disorder—Vemurafenib—skin cancer	0.00142	0.00677	CcSEcCtD
Dronedarone—Skin disorder—Vemurafenib—skin cancer	0.00141	0.00671	CcSEcCtD
Dronedarone—KCNK2—lymph node—skin cancer	0.0014	0.0123	CbGeAlD
Dronedarone—Nausea—Vismodegib—skin cancer	0.00139	0.00664	CcSEcCtD
Dronedarone—Pneumonia—Bleomycin—skin cancer	0.00138	0.0066	CcSEcCtD
Dronedarone—Angioedema—Imiquimod—skin cancer	0.00138	0.00659	CcSEcCtD
Dronedarone—Hypokalaemia—Temozolomide—skin cancer	0.00137	0.00654	CcSEcCtD
Dronedarone—KCNH2—nipple—skin cancer	0.00133	0.0117	CbGeAlD
Dronedarone—ADRA2C—nipple—skin cancer	0.00132	0.0116	CbGeAlD
Dronedarone—Pneumonia—Dactinomycin—skin cancer	0.00129	0.00615	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.00128	0.0061	CcSEcCtD
Dronedarone—CACNB1—lymph node—skin cancer	0.00126	0.0111	CbGeAlD
Dronedarone—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00125	0.00596	CcSEcCtD
Dronedarone—Fatigue—Vemurafenib—skin cancer	0.00125	0.00595	CcSEcCtD
Dronedarone—ADRB1—connective tissue—skin cancer	0.00124	0.0109	CbGeAlD
Dronedarone—Nervous system disorder—Imiquimod—skin cancer	0.00121	0.00578	CcSEcCtD
Dronedarone—CACNB3—lymph node—skin cancer	0.00121	0.0106	CbGeAlD
Dronedarone—ADRA1D—female reproductive system—skin cancer	0.0012	0.0106	CbGeAlD
Dronedarone—Skin disorder—Imiquimod—skin cancer	0.0012	0.00572	CcSEcCtD
Dronedarone—Photosensitivity reaction—Temozolomide—skin cancer	0.00119	0.00567	CcSEcCtD
Dronedarone—Pneumonia—Temozolomide—skin cancer	0.00117	0.00557	CcSEcCtD
Dronedarone—CACNB2—head—skin cancer	0.00116	0.0102	CbGeAlD
Dronedarone—SCN1A—head—skin cancer	0.00113	0.00991	CbGeAlD
Dronedarone—CACNA1C—female reproductive system—skin cancer	0.00112	0.00985	CbGeAlD
Dronedarone—Cardiac failure congestive—Docetaxel—skin cancer	0.0011	0.00527	CcSEcCtD
Dronedarone—Hepatobiliary disease—Temozolomide—skin cancer	0.0011	0.00523	CcSEcCtD
Dronedarone—Photosensitivity reaction—Fluorouracil—skin cancer	0.00109	0.00522	CcSEcCtD
Dronedarone—Dyspepsia—Imiquimod—skin cancer	0.00109	0.00518	CcSEcCtD
Dronedarone—Pneumonia—Fluorouracil—skin cancer	0.00107	0.00513	CcSEcCtD
Dronedarone—Erythema—Bleomycin—skin cancer	0.00107	0.00513	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Imiquimod—skin cancer	0.00107	0.00509	CcSEcCtD
Dronedarone—Fatigue—Imiquimod—skin cancer	0.00106	0.00508	CcSEcCtD
Dronedarone—ADRA2A—nipple—skin cancer	0.00105	0.00924	CbGeAlD
Dronedarone—Asthenia—Vemurafenib—skin cancer	0.00104	0.00496	CcSEcCtD
Dronedarone—ADRA1B—head—skin cancer	0.00103	0.00903	CbGeAlD
Dronedarone—Cardiac failure—Docetaxel—skin cancer	0.00103	0.00489	CcSEcCtD
Dronedarone—Pruritus—Vemurafenib—skin cancer	0.00102	0.00489	CcSEcCtD
Dronedarone—CACNA1D—head—skin cancer	0.00101	0.00891	CbGeAlD
Dronedarone—Gastrointestinal pain—Imiquimod—skin cancer	0.00101	0.00482	CcSEcCtD
Dronedarone—ADRA1D—head—skin cancer	0.00101	0.00884	CbGeAlD
Dronedarone—Erythema—Dactinomycin—skin cancer	0.001	0.00478	CcSEcCtD
Dronedarone—Diarrhoea—Vemurafenib—skin cancer	0.00099	0.00473	CcSEcCtD
Dronedarone—Abdominal pain—Imiquimod—skin cancer	0.000975	0.00466	CcSEcCtD
Dronedarone—Cardiac disorder—Temozolomide—skin cancer	0.000966	0.00461	CcSEcCtD
Dronedarone—Angiopathy—Temozolomide—skin cancer	0.000944	0.00451	CcSEcCtD
Dronedarone—Immune system disorder—Temozolomide—skin cancer	0.00094	0.00449	CcSEcCtD
Dronedarone—Mediastinal disorder—Temozolomide—skin cancer	0.000938	0.00448	CcSEcCtD
Dronedarone—CACNA1C—head—skin cancer	0.000936	0.00823	CbGeAlD
Dronedarone—ADRA1A—epithelium—skin cancer	0.00093	0.00818	CbGeAlD
Dronedarone—Vomiting—Vemurafenib—skin cancer	0.00092	0.00439	CcSEcCtD
Dronedarone—Rash—Vemurafenib—skin cancer	0.000912	0.00435	CcSEcCtD
Dronedarone—Dermatitis—Vemurafenib—skin cancer	0.000911	0.00435	CcSEcCtD
Dronedarone—Erythema—Temozolomide—skin cancer	0.000906	0.00433	CcSEcCtD
Dronedarone—Dysgeusia—Temozolomide—skin cancer	0.000887	0.00424	CcSEcCtD
Dronedarone—Asthenia—Imiquimod—skin cancer	0.000885	0.00423	CcSEcCtD
Dronedarone—Anaphylactic shock—Bleomycin—skin cancer	0.000877	0.00418	CcSEcCtD
Dronedarone—ADRB1—female reproductive system—skin cancer	0.000874	0.00768	CbGeAlD
Dronedarone—Pruritus—Imiquimod—skin cancer	0.000873	0.00417	CcSEcCtD
Dronedarone—Nausea—Vemurafenib—skin cancer	0.000859	0.0041	CcSEcCtD
Dronedarone—Diarrhoea—Imiquimod—skin cancer	0.000844	0.00403	CcSEcCtD
Dronedarone—Erythema—Fluorouracil—skin cancer	0.000835	0.00398	CcSEcCtD
Dronedarone—Angioedema—Temozolomide—skin cancer	0.000828	0.00395	CcSEcCtD
Dronedarone—CACNB2—lymph node—skin cancer	0.000812	0.00714	CbGeAlD
Dronedarone—ABCB1—blood vessel—skin cancer	0.00081	0.00712	CbGeAlD
Dronedarone—Vomiting—Imiquimod—skin cancer	0.000785	0.00375	CcSEcCtD
Dronedarone—Rash—Imiquimod—skin cancer	0.000778	0.00371	CcSEcCtD
Dronedarone—Dermatitis—Imiquimod—skin cancer	0.000777	0.00371	CcSEcCtD
Dronedarone—Pneumonia—Docetaxel—skin cancer	0.000776	0.0037	CcSEcCtD
Dronedarone—ADRA2C—mammalian vulva—skin cancer	0.000769	0.00676	CbGeAlD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000766	0.00366	CcSEcCtD
Dronedarone—ADRA2A—connective tissue—skin cancer	0.000745	0.00655	CbGeAlD
Dronedarone—Anaphylactic shock—Temozolomide—skin cancer	0.00074	0.00353	CcSEcCtD
Dronedarone—Nausea—Imiquimod—skin cancer	0.000733	0.0035	CcSEcCtD
Dronedarone—ADRB1—head—skin cancer	0.00073	0.00642	CbGeAlD
Dronedarone—Hepatobiliary disease—Docetaxel—skin cancer	0.000729	0.00348	CcSEcCtD
Dronedarone—Nervous system disorder—Temozolomide—skin cancer	0.000725	0.00346	CcSEcCtD
Dronedarone—Skin disorder—Temozolomide—skin cancer	0.000718	0.00343	CcSEcCtD
Dronedarone—ADRA1A—lymphoid tissue—skin cancer	0.000716	0.0063	CbGeAlD
Dronedarone—CACNA1D—lymph node—skin cancer	0.00071	0.00624	CbGeAlD
Dronedarone—Fatigue—Dactinomycin—skin cancer	0.000705	0.00336	CcSEcCtD
Dronedarone—Anaphylactic shock—Fluorouracil—skin cancer	0.000681	0.00325	CcSEcCtD
Dronedarone—Gastrointestinal pain—Dactinomycin—skin cancer	0.000669	0.00319	CcSEcCtD
Dronedarone—Nervous system disorder—Fluorouracil—skin cancer	0.000668	0.00319	CcSEcCtD
Dronedarone—KCNH2—female reproductive system—skin cancer	0.000667	0.00587	CbGeAlD
Dronedarone—CACNA1C—lymph node—skin cancer	0.000655	0.00576	CbGeAlD
Dronedarone—Dyspepsia—Temozolomide—skin cancer	0.000651	0.00311	CcSEcCtD
Dronedarone—Abdominal pain—Dactinomycin—skin cancer	0.000646	0.00309	CcSEcCtD
Dronedarone—Cardiac disorder—Docetaxel—skin cancer	0.000642	0.00307	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Temozolomide—skin cancer	0.000638	0.00305	CcSEcCtD
Dronedarone—Fatigue—Temozolomide—skin cancer	0.000638	0.00304	CcSEcCtD
Dronedarone—Asthenia—Bleomycin—skin cancer	0.000629	0.003	CcSEcCtD
Dronedarone—Angiopathy—Docetaxel—skin cancer	0.000628	0.003	CcSEcCtD
Dronedarone—Immune system disorder—Docetaxel—skin cancer	0.000625	0.00298	CcSEcCtD
Dronedarone—Mediastinal disorder—Docetaxel—skin cancer	0.000624	0.00298	CcSEcCtD
Dronedarone—Pruritus—Bleomycin—skin cancer	0.00062	0.00296	CcSEcCtD
Dronedarone—ADRA2A—mammalian vulva—skin cancer	0.000614	0.00539	CbGeAlD
Dronedarone—Gastrointestinal pain—Temozolomide—skin cancer	0.000605	0.00289	CcSEcCtD
Dronedarone—Erythema—Docetaxel—skin cancer	0.000603	0.00288	CcSEcCtD
Dronedarone—Dyspepsia—Fluorouracil—skin cancer	0.0006	0.00286	CcSEcCtD
Dronedarone—Dysgeusia—Docetaxel—skin cancer	0.00059	0.00282	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000588	0.00281	CcSEcCtD
Dronedarone—Asthenia—Dactinomycin—skin cancer	0.000587	0.0028	CcSEcCtD
Dronedarone—Abdominal pain—Temozolomide—skin cancer	0.000585	0.00279	CcSEcCtD
Dronedarone—ADRA1A—head—skin cancer	0.000577	0.00508	CbGeAlD
Dronedarone—Diarrhoea—Dactinomycin—skin cancer	0.000559	0.00267	CcSEcCtD
Dronedarone—KCNH2—head—skin cancer	0.000558	0.0049	CbGeAlD
Dronedarone—Vomiting—Bleomycin—skin cancer	0.000557	0.00266	CcSEcCtD
Dronedarone—Rash—Bleomycin—skin cancer	0.000553	0.00264	CcSEcCtD
Dronedarone—Dermatitis—Bleomycin—skin cancer	0.000552	0.00264	CcSEcCtD
Dronedarone—ADRA2C—head—skin cancer	0.00055	0.00484	CbGeAlD
Dronedarone—Asthenia—Temozolomide—skin cancer	0.000531	0.00253	CcSEcCtD
Dronedarone—ADRA2A—female reproductive system—skin cancer	0.000525	0.00462	CbGeAlD
Dronedarone—Pruritus—Temozolomide—skin cancer	0.000523	0.0025	CcSEcCtD
Dronedarone—Nausea—Bleomycin—skin cancer	0.000521	0.00249	CcSEcCtD
Dronedarone—Vomiting—Dactinomycin—skin cancer	0.00052	0.00248	CcSEcCtD
Dronedarone—Rash—Dactinomycin—skin cancer	0.000516	0.00246	CcSEcCtD
Dronedarone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000509	0.00243	CcSEcCtD
Dronedarone—ALB—lymph node—skin cancer	0.000508	0.00447	CbGeAlD
Dronedarone—Diarrhoea—Temozolomide—skin cancer	0.000506	0.00242	CcSEcCtD
Dronedarone—Anaphylactic shock—Docetaxel—skin cancer	0.000492	0.00235	CcSEcCtD
Dronedarone—Nausea—Dactinomycin—skin cancer	0.000486	0.00232	CcSEcCtD
Dronedarone—Nervous system disorder—Docetaxel—skin cancer	0.000482	0.0023	CcSEcCtD
Dronedarone—Pruritus—Fluorouracil—skin cancer	0.000482	0.0023	CcSEcCtD
Dronedarone—Skin disorder—Docetaxel—skin cancer	0.000478	0.00228	CcSEcCtD
Dronedarone—Vomiting—Temozolomide—skin cancer	0.00047	0.00224	CcSEcCtD
Dronedarone—Rash—Temozolomide—skin cancer	0.000466	0.00223	CcSEcCtD
Dronedarone—Diarrhoea—Fluorouracil—skin cancer	0.000466	0.00223	CcSEcCtD
Dronedarone—Dermatitis—Temozolomide—skin cancer	0.000466	0.00222	CcSEcCtD
Dronedarone—Nausea—Temozolomide—skin cancer	0.000439	0.0021	CcSEcCtD
Dronedarone—ADRA2A—head—skin cancer	0.000439	0.00386	CbGeAlD
Dronedarone—Vomiting—Fluorouracil—skin cancer	0.000433	0.00207	CcSEcCtD
Dronedarone—Dyspepsia—Docetaxel—skin cancer	0.000433	0.00207	CcSEcCtD
Dronedarone—Rash—Fluorouracil—skin cancer	0.00043	0.00205	CcSEcCtD
Dronedarone—Dermatitis—Fluorouracil—skin cancer	0.000429	0.00205	CcSEcCtD
Dronedarone—Gastrointestinal disorder—Docetaxel—skin cancer	0.000425	0.00203	CcSEcCtD
Dronedarone—Fatigue—Docetaxel—skin cancer	0.000424	0.00202	CcSEcCtD
Dronedarone—CYP3A4—female reproductive system—skin cancer	0.000414	0.00364	CbGeAlD
Dronedarone—CYP2D6—female reproductive system—skin cancer	0.000407	0.00358	CbGeAlD
Dronedarone—Nausea—Fluorouracil—skin cancer	0.000405	0.00193	CcSEcCtD
Dronedarone—Gastrointestinal pain—Docetaxel—skin cancer	0.000402	0.00192	CcSEcCtD
Dronedarone—ABCB1—epithelium—skin cancer	0.000394	0.00347	CbGeAlD
Dronedarone—KCNH2—lymph node—skin cancer	0.00039	0.00343	CbGeAlD
Dronedarone—Abdominal pain—Docetaxel—skin cancer	0.000389	0.00186	CcSEcCtD
Dronedarone—ADRA2C—lymph node—skin cancer	0.000385	0.00339	CbGeAlD
Dronedarone—Asthenia—Docetaxel—skin cancer	0.000353	0.00168	CcSEcCtD
Dronedarone—Pruritus—Docetaxel—skin cancer	0.000348	0.00166	CcSEcCtD
Dronedarone—ABCB1—mammalian vulva—skin cancer	0.000342	0.00301	CbGeAlD
Dronedarone—CYP2D6—head—skin cancer	0.00034	0.00299	CbGeAlD
Dronedarone—Diarrhoea—Docetaxel—skin cancer	0.000336	0.00161	CcSEcCtD
Dronedarone—Vomiting—Docetaxel—skin cancer	0.000313	0.00149	CcSEcCtD
Dronedarone—Rash—Docetaxel—skin cancer	0.00031	0.00148	CcSEcCtD
Dronedarone—Dermatitis—Docetaxel—skin cancer	0.00031	0.00148	CcSEcCtD
Dronedarone—ADRA2A—lymph node—skin cancer	0.000307	0.0027	CbGeAlD
Dronedarone—ABCB1—lymphoid tissue—skin cancer	0.000304	0.00267	CbGeAlD
Dronedarone—ABCB1—female reproductive system—skin cancer	0.000293	0.00257	CbGeAlD
Dronedarone—Nausea—Docetaxel—skin cancer	0.000292	0.00139	CcSEcCtD
Dronedarone—ABCB1—head—skin cancer	0.000245	0.00215	CbGeAlD
Dronedarone—ABCB1—lymph node—skin cancer	0.000171	0.00151	CbGeAlD
Dronedarone—CACNB2—Developmental Biology—NRAS—skin cancer	2.73e-05	0.0008	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—GLI1—skin cancer	2.72e-05	0.000796	CbGpPWpGaD
Dronedarone—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—skin cancer	2.69e-05	0.000786	CbGpPWpGaD
Dronedarone—CACNB2—Axon guidance—IL6—skin cancer	2.68e-05	0.000785	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—SMO—skin cancer	2.66e-05	0.000779	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—PTCH1—skin cancer	2.66e-05	0.000779	CbGpPWpGaD
Dronedarone—CACNA1D—Axon guidance—HRAS—skin cancer	2.65e-05	0.000776	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—GLI2—skin cancer	2.64e-05	0.000772	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—SMO—skin cancer	2.62e-05	0.000767	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—PTCH1—skin cancer	2.62e-05	0.000767	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—PTCH2—skin cancer	2.62e-05	0.000766	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—GLI2—skin cancer	2.61e-05	0.000765	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—PTGER4—skin cancer	2.59e-05	0.000759	CbGpPWpGaD
Dronedarone—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—skin cancer	2.59e-05	0.000758	CbGpPWpGaD
Dronedarone—CACNA1D—Developmental Biology—NRAS—skin cancer	2.59e-05	0.000757	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—SUFU—skin cancer	2.58e-05	0.000755	CbGpPWpGaD
Dronedarone—KCNH2—Neuronal System—HRAS—skin cancer	2.57e-05	0.000753	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—PTGER4—skin cancer	2.55e-05	0.000747	CbGpPWpGaD
Dronedarone—CACNA1D—Axon guidance—IL6—skin cancer	2.54e-05	0.000743	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—MC1R—skin cancer	2.52e-05	0.000736	CbGpPWpGaD
Dronedarone—ADRA1A—GPCR downstream signaling—PTGER4—skin cancer	2.5e-05	0.00073	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—MC1R—skin cancer	2.49e-05	0.00073	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—GLI1—skin cancer	2.48e-05	0.000726	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—GLI1—skin cancer	2.46e-05	0.000719	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—SHH—skin cancer	2.46e-05	0.000719	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—GLI2—skin cancer	2.44e-05	0.000714	CbGpPWpGaD
Dronedarone—ALB—Selenium Micronutrient Network—IL6—skin cancer	2.41e-05	0.000706	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—GLI2—skin cancer	2.4e-05	0.000703	CbGpPWpGaD
Dronedarone—SCN1A—Developmental Biology—HRAS—skin cancer	2.39e-05	0.0007	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—CSPG4—skin cancer	2.37e-05	0.000694	CbGpPWpGaD
Dronedarone—CACNB2—Developmental Biology—KRAS—skin cancer	2.35e-05	0.000688	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—SUFU—skin cancer	2.35e-05	0.000688	CbGpPWpGaD
Dronedarone—CACNA1S—Developmental Biology—HRAS—skin cancer	2.33e-05	0.000682	CbGpPWpGaD
Dronedarone—CACNA1C—Axon guidance—HRAS—skin cancer	2.33e-05	0.000682	CbGpPWpGaD
Dronedarone—CACNB2—Metabolism—ERCC2—skin cancer	2.33e-05	0.000682	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—SUFU—skin cancer	2.33e-05	0.000682	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—MC1R—skin cancer	2.33e-05	0.000681	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—PTCH1—skin cancer	2.33e-05	0.000681	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—SMO—skin cancer	2.33e-05	0.000681	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PLIN2—skin cancer	2.32e-05	0.000679	CbGpPWpGaD
Dronedarone—ADRA2A—GPCR downstream signaling—PTGER4—skin cancer	2.32e-05	0.000678	CbGpPWpGaD
Dronedarone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—skin cancer	2.3e-05	0.000673	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—GLI1—skin cancer	2.3e-05	0.000672	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—MC1R—skin cancer	2.29e-05	0.000671	CbGpPWpGaD
Dronedarone—SCN1A—Developmental Biology—IL6—skin cancer	2.29e-05	0.00067	CbGpPWpGaD
Dronedarone—CACNB3—Metabolism—PTGS2—skin cancer	2.29e-05	0.000669	CbGpPWpGaD
Dronedarone—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	2.28e-05	0.000668	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—SHH—skin cancer	2.28e-05	0.000668	CbGpPWpGaD
Dronedarone—CACNA1C—Developmental Biology—NRAS—skin cancer	2.27e-05	0.000665	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—PTGER4—skin cancer	2.27e-05	0.000663	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—GLI1—skin cancer	2.26e-05	0.000661	CbGpPWpGaD
Dronedarone—CACNA1S—Developmental Biology—IL6—skin cancer	2.23e-05	0.000653	CbGpPWpGaD
Dronedarone—CACNA1C—Axon guidance—IL6—skin cancer	2.23e-05	0.000653	CbGpPWpGaD
Dronedarone—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—skin cancer	2.23e-05	0.000652	CbGpPWpGaD
Dronedarone—CACNA1D—Developmental Biology—KRAS—skin cancer	2.23e-05	0.000652	CbGpPWpGaD
Dronedarone—CACNA1D—Metabolism—ERCC2—skin cancer	2.21e-05	0.000646	CbGpPWpGaD
Dronedarone—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	2.18e-05	0.000639	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—SUFU—skin cancer	2.18e-05	0.000637	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—PTCH1—skin cancer	2.16e-05	0.000633	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—SMO—skin cancer	2.16e-05	0.000633	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—SUFU—skin cancer	2.14e-05	0.000627	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—GLI2—skin cancer	2.13e-05	0.000624	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—PTGER4—skin cancer	2.11e-05	0.000616	CbGpPWpGaD
Dronedarone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	2.09e-05	0.000611	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—MC1R—skin cancer	2.04e-05	0.000596	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PLIN2—skin cancer	2.03e-05	0.000595	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—GLI1—skin cancer	2.01e-05	0.000587	CbGpPWpGaD
Dronedarone—CACNB2—Developmental Biology—HRAS—skin cancer	2e-05	0.000585	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—ENO2—skin cancer	1.98e-05	0.000581	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—GLI2—skin cancer	1.98e-05	0.00058	CbGpPWpGaD
Dronedarone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—skin cancer	1.98e-05	0.000579	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—SHH—skin cancer	1.97e-05	0.000576	CbGpPWpGaD
Dronedarone—CACNA1C—Developmental Biology—KRAS—skin cancer	1.96e-05	0.000573	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—RASA1—skin cancer	1.96e-05	0.000572	CbGpPWpGaD
Dronedarone—CACNA1C—Metabolism—ERCC2—skin cancer	1.94e-05	0.000567	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PLIN2—skin cancer	1.92e-05	0.000561	CbGpPWpGaD
Dronedarone—CACNB2—Developmental Biology—IL6—skin cancer	1.91e-05	0.00056	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—SUFU—skin cancer	1.9e-05	0.000557	CbGpPWpGaD
Dronedarone—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	1.89e-05	0.000554	CbGpPWpGaD
Dronedarone—CACNA1D—Developmental Biology—HRAS—skin cancer	1.89e-05	0.000554	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—MC1R—skin cancer	1.89e-05	0.000553	CbGpPWpGaD
Dronedarone—ALB—Metabolism—CSPG4—skin cancer	1.87e-05	0.000548	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—PTCH1—skin cancer	1.87e-05	0.000546	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—SMO—skin cancer	1.87e-05	0.000546	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—GLI1—skin cancer	1.86e-05	0.000546	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—PTGER4—skin cancer	1.82e-05	0.000531	CbGpPWpGaD
Dronedarone—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	1.81e-05	0.00053	CbGpPWpGaD
Dronedarone—CACNA1D—Developmental Biology—IL6—skin cancer	1.81e-05	0.00053	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—SHH—skin cancer	1.79e-05	0.000525	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—RASA1—skin cancer	1.78e-05	0.000521	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—SHH—skin cancer	1.78e-05	0.00052	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—SUFU—skin cancer	1.77e-05	0.000517	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—RASA1—skin cancer	1.77e-05	0.000517	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—PTCH1—skin cancer	1.7e-05	0.000497	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—SMO—skin cancer	1.7e-05	0.000497	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—PTCH1—skin cancer	1.68e-05	0.000493	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—SMO—skin cancer	1.68e-05	0.000493	CbGpPWpGaD
Dronedarone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	1.68e-05	0.000492	CbGpPWpGaD
Dronedarone—CACNA1C—Developmental Biology—HRAS—skin cancer	1.66e-05	0.000487	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—SHH—skin cancer	1.66e-05	0.000486	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—PTGER4—skin cancer	1.65e-05	0.000484	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—RASA1—skin cancer	1.65e-05	0.000483	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—CSPG4—skin cancer	1.64e-05	0.00048	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—PTGER4—skin cancer	1.64e-05	0.00048	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—SHH—skin cancer	1.63e-05	0.000478	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—RASA1—skin cancer	1.62e-05	0.000475	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—ENO2—skin cancer	1.61e-05	0.000472	CbGpPWpGaD
Dronedarone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	1.61e-05	0.000471	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—FOXO4—skin cancer	1.6e-05	0.000469	CbGpPWpGaD
Dronedarone—CACNA1C—Developmental Biology—IL6—skin cancer	1.59e-05	0.000466	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—PTCH1—skin cancer	1.57e-05	0.00046	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—SMO—skin cancer	1.57e-05	0.00046	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—PTCH1—skin cancer	1.55e-05	0.000453	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—SMO—skin cancer	1.55e-05	0.000453	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—CSPG4—skin cancer	1.55e-05	0.000452	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—PTGER4—skin cancer	1.53e-05	0.000448	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—PTGER4—skin cancer	1.51e-05	0.000441	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—FOXO4—skin cancer	1.46e-05	0.000428	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—SHH—skin cancer	1.45e-05	0.000424	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—FOXO4—skin cancer	1.45e-05	0.000424	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—RASA1—skin cancer	1.44e-05	0.000422	CbGpPWpGaD
Dronedarone—ADRA2B—Hemostasis—NRAS—skin cancer	1.42e-05	0.000416	CbGpPWpGaD
Dronedarone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	1.4e-05	0.000409	CbGpPWpGaD
Dronedarone—CACNB2—Metabolism—PTGS2—skin cancer	1.4e-05	0.000409	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—SMO—skin cancer	1.38e-05	0.000402	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—PTCH1—skin cancer	1.38e-05	0.000402	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—FOXO4—skin cancer	1.35e-05	0.000396	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—SHH—skin cancer	1.35e-05	0.000394	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—RASA1—skin cancer	1.34e-05	0.000392	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—PTGER4—skin cancer	1.34e-05	0.000392	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—FOXO4—skin cancer	1.33e-05	0.00039	CbGpPWpGaD
Dronedarone—ADRA2C—Hemostasis—NRAS—skin cancer	1.33e-05	0.000388	CbGpPWpGaD
Dronedarone—CACNA1D—Metabolism—PTGS2—skin cancer	1.32e-05	0.000387	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—SMO—skin cancer	1.28e-05	0.000374	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—PTCH1—skin cancer	1.28e-05	0.000374	CbGpPWpGaD
Dronedarone—ALB—Metabolism—ENO2—skin cancer	1.27e-05	0.000372	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PLIN2—skin cancer	1.25e-05	0.000367	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—PTGER4—skin cancer	1.24e-05	0.000364	CbGpPWpGaD
Dronedarone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	1.24e-05	0.000364	CbGpPWpGaD
Dronedarone—ADRA2B—Hemostasis—KRAS—skin cancer	1.22e-05	0.000358	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—FOXO4—skin cancer	1.18e-05	0.000346	CbGpPWpGaD
Dronedarone—CACNA1C—Metabolism—PTGS2—skin cancer	1.16e-05	0.00034	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—ERCC2—skin cancer	1.15e-05	0.000337	CbGpPWpGaD
Dronedarone—ADRA2C—Hemostasis—KRAS—skin cancer	1.14e-05	0.000334	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—ENO2—skin cancer	1.11e-05	0.000326	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—FOXO4—skin cancer	1.1e-05	0.000322	CbGpPWpGaD
Dronedarone—ADRA2B—Hemostasis—TP53—skin cancer	1.09e-05	0.000318	CbGpPWpGaD
Dronedarone—ADRA2A—Hemostasis—NRAS—skin cancer	1.08e-05	0.000315	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—TERT—skin cancer	1.07e-05	0.000313	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—ENO2—skin cancer	1.05e-05	0.000307	CbGpPWpGaD
Dronedarone—ADRA2B—Hemostasis—HRAS—skin cancer	1.04e-05	0.000304	CbGpPWpGaD
Dronedarone—ADRA2C—Hemostasis—TP53—skin cancer	1.01e-05	0.000297	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—CSPG4—skin cancer	1.01e-05	0.000296	CbGpPWpGaD
Dronedarone—ALB—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	9.95e-06	0.000291	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—TERT—skin cancer	9.76e-06	0.000286	CbGpPWpGaD
Dronedarone—ADRA2C—Hemostasis—HRAS—skin cancer	9.71e-06	0.000284	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—TERT—skin cancer	9.67e-06	0.000283	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—ERCC2—skin cancer	9.37e-06	0.000274	CbGpPWpGaD
Dronedarone—ADRA2A—Hemostasis—KRAS—skin cancer	9.27e-06	0.000271	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—TERT—skin cancer	9.04e-06	0.000264	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—NRAS—skin cancer	9.03e-06	0.000264	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—TERT—skin cancer	8.89e-06	0.00026	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—NRAS—skin cancer	8.5e-06	0.000249	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—BRAF—skin cancer	8.49e-06	0.000248	CbGpPWpGaD
Dronedarone—ADRA2A—Hemostasis—TP53—skin cancer	8.24e-06	0.000241	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—NRAS—skin cancer	8.23e-06	0.000241	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—NRAS—skin cancer	8.15e-06	0.000238	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—TERT—skin cancer	7.9e-06	0.000231	CbGpPWpGaD
Dronedarone—ADRA2A—Hemostasis—HRAS—skin cancer	7.88e-06	0.000231	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—KRAS—skin cancer	7.77e-06	0.000227	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—BRAF—skin cancer	7.73e-06	0.000226	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—BRAF—skin cancer	7.66e-06	0.000224	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—NRAS—skin cancer	7.61e-06	0.000223	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—NRAS—skin cancer	7.49e-06	0.000219	CbGpPWpGaD
Dronedarone—ALB—Metabolism—ERCC2—skin cancer	7.39e-06	0.000216	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—TERT—skin cancer	7.34e-06	0.000215	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—KRAS—skin cancer	7.32e-06	0.000214	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—BRAF—skin cancer	7.16e-06	0.000209	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—KRAS—skin cancer	7.08e-06	0.000207	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—BRAF—skin cancer	7.04e-06	0.000206	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—KRAS—skin cancer	7.02e-06	0.000205	CbGpPWpGaD
Dronedarone—ADRA2C—Metabolism—PTGS2—skin cancer	6.91e-06	0.000202	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—ENO2—skin cancer	6.87e-06	0.000201	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—NRAS—skin cancer	6.66e-06	0.000195	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—HRAS—skin cancer	6.61e-06	0.000193	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—KRAS—skin cancer	6.55e-06	0.000192	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—TP53—skin cancer	6.51e-06	0.00019	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—ERCC2—skin cancer	6.48e-06	0.000189	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—KRAS—skin cancer	6.45e-06	0.000189	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling by GPCR—IL6—skin cancer	6.32e-06	0.000185	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—BRAF—skin cancer	6.26e-06	0.000183	CbGpPWpGaD
Dronedarone—ALB—Hemostasis—HRAS—skin cancer	6.22e-06	0.000182	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—NRAS—skin cancer	6.18e-06	0.000181	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—ERCC2—skin cancer	6.1e-06	0.000179	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—HRAS—skin cancer	6.02e-06	0.000176	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—HRAS—skin cancer	5.96e-06	0.000174	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—BRAF—skin cancer	5.81e-06	0.00017	CbGpPWpGaD
Dronedarone—ADRB1—Signaling by GPCR—IL6—skin cancer	5.76e-06	0.000169	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—KRAS—skin cancer	5.73e-06	0.000168	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling by GPCR—IL6—skin cancer	5.71e-06	0.000167	CbGpPWpGaD
Dronedarone—ADRA2A—Metabolism—PTGS2—skin cancer	5.62e-06	0.000164	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—HRAS—skin cancer	5.57e-06	0.000163	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—HRAS—skin cancer	5.48e-06	0.00016	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—NRAS—skin cancer	5.33e-06	0.000156	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling by GPCR—IL6—skin cancer	5.33e-06	0.000156	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—KRAS—skin cancer	5.32e-06	0.000156	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling by GPCR—IL6—skin cancer	5.25e-06	0.000153	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—HRAS—skin cancer	4.87e-06	0.000142	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—NRAS—skin cancer	4.86e-06	0.000142	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—NRAS—skin cancer	4.82e-06	0.000141	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling by GPCR—IL6—skin cancer	4.66e-06	0.000136	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—KRAS—skin cancer	4.59e-06	0.000134	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—HRAS—skin cancer	4.52e-06	0.000132	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—NRAS—skin cancer	4.5e-06	0.000132	CbGpPWpGaD
Dronedarone—ALB—Metabolism—PTGS2—skin cancer	4.43e-06	0.00013	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—NRAS—skin cancer	4.43e-06	0.000129	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling by GPCR—IL6—skin cancer	4.33e-06	0.000127	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—KRAS—skin cancer	4.18e-06	0.000122	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—KRAS—skin cancer	4.14e-06	0.000121	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—TP53—skin cancer	4.08e-06	0.000119	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—ERCC2—skin cancer	3.99e-06	0.000117	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—NRAS—skin cancer	3.93e-06	0.000115	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—HRAS—skin cancer	3.9e-06	0.000114	CbGpPWpGaD
Dronedarone—ABCB1—Metabolism—PTGS2—skin cancer	3.88e-06	0.000114	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—KRAS—skin cancer	3.87e-06	0.000113	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—KRAS—skin cancer	3.81e-06	0.000111	CbGpPWpGaD
Dronedarone—ADRA1D—Signaling Pathways—IL6—skin cancer	3.73e-06	0.000109	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—TP53—skin cancer	3.72e-06	0.000109	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—TP53—skin cancer	3.68e-06	0.000108	CbGpPWpGaD
Dronedarone—CYP2D6—Metabolism—PTGS2—skin cancer	3.66e-06	0.000107	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—NRAS—skin cancer	3.65e-06	0.000107	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—HRAS—skin cancer	3.56e-06	0.000104	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—HRAS—skin cancer	3.52e-06	0.000103	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—TP53—skin cancer	3.44e-06	0.000101	CbGpPWpGaD
Dronedarone—ADRB1—Signaling Pathways—IL6—skin cancer	3.4e-06	9.95e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—TP53—skin cancer	3.39e-06	9.91e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—KRAS—skin cancer	3.38e-06	9.9e-05	CbGpPWpGaD
Dronedarone—ADRA2B—Signaling Pathways—IL6—skin cancer	3.37e-06	9.86e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—HRAS—skin cancer	3.29e-06	9.63e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—HRAS—skin cancer	3.24e-06	9.47e-05	CbGpPWpGaD
Dronedarone—ADRA2C—Signaling Pathways—IL6—skin cancer	3.15e-06	9.21e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—KRAS—skin cancer	3.14e-06	9.2e-05	CbGpPWpGaD
Dronedarone—ADRA1B—Signaling Pathways—IL6—skin cancer	3.1e-06	9.07e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—TP53—skin cancer	3.01e-06	8.8e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—HRAS—skin cancer	2.88e-06	8.42e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—TP53—skin cancer	2.79e-06	8.18e-05	CbGpPWpGaD
Dronedarone—ADRA1A—Signaling Pathways—IL6—skin cancer	2.75e-06	8.05e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—HRAS—skin cancer	2.67e-06	7.82e-05	CbGpPWpGaD
Dronedarone—ADRA2A—Signaling Pathways—IL6—skin cancer	2.56e-06	7.48e-05	CbGpPWpGaD
Dronedarone—CYP3A4—Metabolism—PTGS2—skin cancer	2.39e-06	7e-05	CbGpPWpGaD
